GPBAR1 and type 2 diabetes mellitus: TGR5 has emerged as a promising target in the context of T2DM owing to its involvement in glucose homeostasis, energy expenditure, and anti-inflammatory pathways (Sato et al., 2007; Bhimanwar and Mittal, 2021).